Prostate Cancer Screening — A Perspective on the Current State of the Evidence
Paul F. Pinsky, Ph.D., Philip C. Prorok, Ph.D., and Barnett S. Kramer, M.D., M.P.H. N Engl J Med 2017; 376:1285-1289March 30, 2017DOI: 10.1056/NEJMsb1616281
Controversy continues to roil around the role of PSA screening in prostate cancer. The authors review the available data and its quality and conclude that the evidence does not indicate that the benefits outweigh the harms.